Search

The Gerstner Sloan Kettering Summer Undergraduate Research Program has welcomed 24 students to Sloan Kettering Institute labs for a ten-week course of study mentored by GSK faculty.

… Wednesday, June 11, 2014 The 2014 Gerstner Sloan Kettering Summer Undergraduate Research Program (SURP) , which will run from June 2 to August 8, includes 24 students from 21 different institutions. The students are assigned to GSK faculty mentors and will work in Sloan Kettering Institute labs learning

Hear from Abby Wood, a survivor of Hodgkin lymphoma, who is now giving back to MSK through fundraising with Cycle for Survival.

… Friday, September 28, 2018 Summary This story originally appeared in Bridges, MSK’s newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how to

New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.

… Wednesday, September 18, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available

Discover the role of the work environment in the life and career of an employee with cancer.

… Wednesday, February 8, 2017 Summary Breast cancer patients who worked for supportive employers were more likely to hang onto their jobs after treatment than women who didn’t, according to a new study led by Memorial Sloan Kettering medical oncologist Victoria Blinder . Hear how one woman navigated life

For clinical research stakeholders, implementing and scaling electronic source date (eSource) is a priority. With participation from MSK, a number of Society of Clinical Data Management (SCDM) working groups have collaborated on a paper outlining consensus recommendations on eSource best practices.

… Tuesday, January 13, 2026 For clinical research stakeholders, implementing and scaling electronic source date (eSource) is a priority. With participation from MSK, a number of  Society of Clinical Data Management (SCDM) working groups have collaborated on a paper outlining consensus recommendations on

Results to be presented at the upcoming American Society of Clinical Oncology (ASCO) meeting suggest combination immunotherapy may help more people with the most common form of lung cancer.

… Wednesday, June 1, 2016 Summary Immunotherapy has emerged as a promising new treatment option for people with lung cancer . MSK scientists are conducting research to enable more patients to benefit from immunotherapies, at earlier stages. We spoke with MSK lung cancer and immunotherapy expert Matthew

Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. MSK was also ranked first in gynecology.

… Tuesday, July 30, 2019 Memorial Sloan Kettering Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to  U.S. News & World Report  in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK

Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.

… Saturday, June 2, 2007 Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy

Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers.

… Thursday, March 1, 2012 Summary Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers. Ping Chi has been named an incumbent of a Geoffrey Beene

The Society of Memorial Sloan Kettering Cancer Center (MSK), an organization of dedicated volunteers, raised an extraordinary $6.6 million in their 2022–2023 season, fueling innovations in cancer care, research, and education.

… Monday, June 10, 2024 The Society of Memorial Sloan Kettering Cancer Center (MSK), an organization of dedicated volunteers, raised an extraordinary $6.6 million in their 2022–2023 season, fueling innovations in cancer care, research, and education. Infographic text: The Society raised an extraordinary